News and Media


WADA Executive Committee Approves 2010 Prohibited List

At its September 19, 2009, meeting, WADA’s Executive Committee approved the List of Prohibited Substances and Methods for 2010. The new List will now be officialized and published on WADA’s Web site by October 1, 2009. It will take effect on January 1, 2010.
The Prohibited List is one of the cornerstones of the harmonized fight against doping. It specifies substances and methods prohibited in sport. Its implementation is mandatory for organizations that have adopted the World Anti-Doping Code.
“The annual revision of the List is an elaborate and dynamic process involving international scientific experts and the solicitation of input from stakeholders so that changes are founded on expanding anti-doping knowledge, evidence from the field, and constantly growing understanding of doping practices and trends,” said WADA’s President John Fahey. “This process is highly consultative and WADA’s role is one of facilitation. I am satisfied that, once again, the 2010 List reflects the latest scientific advances.”

Change of Status for Salbutamol
The 2010 List offers a number of changes compared to the 2009 List. In particular, the status of salbutamol, a beta-2 agonist, will change. Salbutamol – a substance considered as specified and therefore more likely to result in a sanction of a warning to a two-year ban in case of anti-doping rule violations – will be permitted under 1,000 nanograms per millilitre. Under the 2010 List, its use by inhalation will no longer require a Therapeutic Use Exemption (TUE) but rather a simplified declaration of use. This measure will allow the handling of salbutamol by anti-doping organizations in a more cost-efficient way. 

In addition, the 2010 List will no longer prohibit supplemental oxygen (hyperoxia).. The status of platelet-derived preparations (e.g. Platelet Rich Plasma, “blood spinning”) has also been clarified. These preparations will be prohibited when administered by intramuscular route. Other routes of administration will require a declaration of use in compliance with the International Standard for TUEs.

Pseudoephedrine Reintroduced
Another noteworthy amendment is the reintroduction of pseudoephedrine to the List as a specified stimulant – a category of substances that is more likely to result in a sanction of a warning to a two-year ban in case of anti-doping rule violations.

Book on Ethical Issues
The Executive Committee approved a special book project to be commissioned by WADA as part of the Agency’s tenth anniversary. This book – to be written by Dr Thomas Murray, President of the Hastings Center in Garrison, United States – will address the ethical issues surround doping and doping-free sport. It will seek to advance knowledge in the field of social science and to provide an alternative vision of the future of sport based on ethical reasoning and an appreciation of the forces that shape elite sport.

Based on Wada newsletter, reedited by IWF